Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Sacks Natalie Create: Alert

All | News | Filings
Date FiledTypeDescription
02/23/2023 4 Sacks Natalie (Director) has filed a Form 4 on Caribou Biosciences, Inc.
Txns: Granted 21,500 options to buy @ $6.12, valued at $131.6k
12/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 155,000 options to buy @ $5.03, valued at $779.7k
12/21/2021 4 Sacks Natalie (Director) has filed a Form 4 on Caribou Biosciences, Inc.
Txns: Granted 27,500 options to buy @ $15.16, valued at $416.9k
11/15/2021 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 155,000 options to buy @ $7.73, valued at $1.2M
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2021 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 80,000 options to buy @ $18.66, valued at $1.5M
05/20/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 1,522 shares @ $14.7691, valued at $22.5k
Exercised 1,522 options to buy @ $2.12, valued at $3.2k
05/12/2020 4 Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $35.49, valued at $319.4k
05/05/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $12.0668, valued at $70.3k
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
04/17/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 500 shares @ $12, valued at $6k
Sold 1,021 shares @ $12.0765, valued at $12.3k
Exercised 500 options to buy @ $2.12, valued at $1.1k
Exercised 1,021 options to buy @ $2.12, valued at $2.2k
04/15/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 4,556 shares @ $12.063, valued at $55k
Exercised 4,556 options to buy @ $2.12, valued at $9.7k
04/08/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 700 shares @ $12.0014, valued at $8.4k
Sold 570 shares @ $12, valued at $6.8k
Exercised 700 options to buy @ $2.12, valued at $1.5k
Exercised 570 options to buy @ $2.12, valued at $1.2k
03/18/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 1 shares @ $12, valued at $12
Sold 1,520 shares @ $12, valued at $18.2k
Exercised 1 options to buy @ $2.12, valued at $2.1
Exercised 1,520 options to buy @ $2.12, valued at $3.2k
03/03/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $14.68, valued at $85.5k
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
02/20/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 1,521 shares @ $15, valued at $22.8k
Exercised 1,521 options to buy @ $2.12, valued at $3.2k
02/04/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $13.9043, valued at $81k
Granted 75,440 options to buy @ $13.29, valued at $1M
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
01/21/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 1,521 shares @ $14.9408, valued at $22.7k
Exercised 1,521 options to buy @ $2.12, valued at $3.2k
01/06/2020 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $14.1779, valued at $82.6k
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
12/18/2019 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 1,521 shares @ $17.0201, valued at $25.9k
Exercised 1,521 options to buy @ $2.12, valued at $3.2k
12/04/2019 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $17.98, valued at $104.8k
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
11/19/2019 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 17,252 shares @ $13.3297, valued at $230k
Sold 1,000 shares @ $14, valued at $14k
Exercised 18,252 options to buy @ $2.12, valued at $38.7k
11/05/2019 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 5,826 shares @ $13.1654, valued at $76.7k
Exercised 5,826 options to buy @ $2.12, valued at $12.4k
10/16/2019 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Sold 12,452 shares @ $13.2734, valued at $165.3k
Sold 11,698 shares @ $13.2058, valued at $154.5k
Exercised 12,452 options to buy @ $2.12, valued at $26.4k
Exercised 11,698 options to buy @ $2.12, valued at $24.8k
05/08/2019 4 Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 10,000 options to buy @ $19.11, valued at $191.1k
09/14/2018 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 87,200 shares @ $0
Sold 3,028 shares @ $6.4993, valued at $19.7k
09/06/2018 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Sold 4,504 shares @ $7.1268, valued at $32.1k
02/12/2018 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 174,400 options to buy @ $6.05, valued at $1.1M
12/13/2017 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 16,312 shares @ $0
09/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/14/2016 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 50,000 shares @ $0
Granted 250,000 options to buy @ $14.29, valued at $3.6M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy